SINT vs VTRS · rev $832.0K vs rev $7.27B
SINTX Technologies Inc (SINT) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
SINTX Technologies Inc (SINT) is a medical devices company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported SINT revenue for 2026-06-30 was $832.0K. Net income was -$5.5M. SINT currently screens at market cap $12.6M.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
SINT currently screens at market cap $12.6M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the SINT and VTRS stock pages for the full models.
Not investment advice.